Effects of vaccine dose, virus challenge dose and interval from vaccination to challenge on protection of broiler chickens against Marek's disease virus challenge

被引:20
作者
Islam, A. F. M. F. [1 ]
Walkden-Brown, S. W.
Groves, P. J.
Underwood, G. J.
机构
[1] Univ New England, Ctr Anim Hlth & Welfare, Sch Rural Sci & Agr, Armidale, NSW 2351, Australia
[2] Zootechny Pty Ltd, Bringelly, NSW 2171, Australia
[3] Bioproperties Pty Ltd, Ringwood, Vic 3134, Australia
关键词
Marek's disease; poultry; turkey herpesvirus vaccine;
D O I
10.1111/j.1751-0813.2007.00195.x
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Objectives To examine the effects of varying the doses of turkey herpesvirus ( HVT) vaccine and Marek's disease virus ( MDV) challenge at two intervals after vaccination on the protection of chickens against challenge with MDV. Design and procedure Experiment 1, a dose response study, consisted of 11 doses of HVT vaccine administered at hatch followed by challenge with 100 plaque forming units ( pfu) of MDV 5 days post vaccination. Experiment 2, a 2 x 6 x 2 factorial design, included two HVT vaccine types, six different doses of HVT vaccine and 50 pfu and 200 pfu of MDV challenge 2 days post vaccination. All chickens were reared up to day 56 post challenge when all survivors were killed humanely. Dead and killed chickens were examined for gross MD tumours. Results Experiment 1 showed a significant positive linear relationship between dose of HVT vaccine and protective index in chickens challenged 5 days post vaccination. However the range of protective index observed was limited. In Experiment 2 neither HVT vaccine provided significant protection at any dose. There was no significant effect of vaccine type or MDV challenge dose on overall protection against challenge. Chickens challenged with 200 pfu of MDV had significantly higher mortality and MD incidence than those with 50 pfu. Conclusions HVT vaccine dose had a significant impact on protective index, but vaccination to challenge interval appeared to have greater impact on the protective efficacy of vaccination. A fourfold increase in challenge dose increased mortality rate and incidence of MD.
引用
收藏
页码:348 / 355
页数:8
相关论文
共 26 条
[1]  
[Anonymous], 2004, MAREKS DIS EVOLVING, DOI DOI 10.1016/B978-012088379-0/50010-4
[2]   Absolute quantitation of Marek's disease virus genome copy number in chicken feather and lymphocyte samples using real-time PCR [J].
Baigent, SJ ;
Petherbridge, LJ ;
Howes, K ;
Smith, LP ;
Currie, RJW ;
Nair, VK .
JOURNAL OF VIROLOGICAL METHODS, 2005, 123 (01) :53-64
[3]  
BERMUDEZ AJ, 2003, DIS POULTRY, P17
[4]  
Bublot M, 2004, MAREKS DIS EVOLVING, P268
[5]  
Calnek BW, 2001, CURR TOP MICROBIOL, V255, P25
[6]   The development and evaluation of two tissue culture-grown Marek's disease challenge viruses [J].
De Laney, DB ;
Morrow, CJ ;
Read, KM ;
Tannock, GA .
AVIAN PATHOLOGY, 1998, 27 (05) :472-477
[7]   CELL-FREE OR CELL-ASSOCIATED TURKEY HERPESVIRUS VACCINE AGAINST MAREKS-DISEASE IN CHICKENS AS INFLUENCED BY MATERNAL ANTIBODY, VACCINE DOSE, AND TIME OF EXPOSURE TO MAREKS-DISEASE VIRUS [J].
EIDSON, CS ;
PAGE, RK ;
KLEVEN, SH .
AVIAN DISEASES, 1978, 22 (04) :583-597
[8]   MODELING THE POTENTIAL IMPACT OF EXOTIC DISEASES ON REGIONAL AUSTRALIA [J].
GARNER, MG ;
LACK, MB .
AUSTRALIAN VETERINARY JOURNAL, 1995, 72 (03) :81-87
[9]   Four distinct neurologic syndromes in Marek's disease: Effect of viral strain and pathotype [J].
Gimeno, IM ;
Witter, RL ;
Reed, WM .
AVIAN DISEASES, 1999, 43 (04) :721-737
[10]   The use of serotype 1-and serotype 3-specific polymerase chain reaction for the detection of Marek's disease virus in chickens [J].
Handberg, KJ ;
Nielsen, OL ;
Jorgensen, PH .
AVIAN PATHOLOGY, 2001, 30 (03) :243-249